View drug registration information details.
Items | Registration information |
ID | 1 |
No | 1 |
Brand Name | GLYCIKAM SR 500 |
Ingredients | METFORMIN HYDROCHLORIDE BP 500 MG |
Dosage Form | PROLONGED RELEASE TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE BELOW 30 C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | ANTIDIABETE |
Indications | TREATMENT OF TYPE 2 DIABETES MELLITUS IN ADULTS, PARTICULARY IN OVERWEIGHT PATIENTS, WHEN DIETARY MANAGEMENT AND EXCERCISE ALONE DOES NOT RESULT IN ADEQUATE GLYCAEMIC CONTROL, MAY BE USED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ORAL ANTIDIABETIC AGENTS OR WITH INSULIN. |
Contraindications | HYPERSENSITIVITY, DIABETIC PRE-COMA, SEVERE RENAL FAILURE, DEHYDRATION, SEVERE INFECTION, SHOCK, DECONPENSATE, RESPIRATORY FAILURE, RECENT MYOCARDIAL INFARCTION, SHOCK, HEPATIC INSUFFICIENCY |
Side Effects | VITAMIIN B12 DEFICIENCY, |
Unit Price | |
EDL |
Yes |
Description | WHITE COLORED, CAPSULE SHAPED, BICONVEX, UNCOATED PROLONGED RELEASE TABLET, BREAKLINE ON ONE SIDE AND PLAIN ON THE OTHER |
Note | |
License Owner | ASA LAO SOLE COMPANY LIMITED |
Manufacturer | IMPULSE PHARMA PVT. LTD |
Country | INDIA |
Import Registration No | KD641 (FORM 25) |
Import Registration Date | 2022-10-02 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-02-23 |
FDD Registration No | 09 I 5796/24 |
FDD Registration Date | 2024-09-25 |
Expiry Date | 2029-09-24 |
Back to drug list
|